Usefulness of high-sensitive troponin elevation after effort stress to unveil vulnerable myocardium in patients with heart failure

American Journal of Cardiology

Volumn 116, Issue 4, 2015, Pages 567-572

  Pastormerlo, Luigi Emilio ^a,b   Agazio, Assunta ^a   Benelli, Eleonora ^a   Gabutti, Alessandra ^a   Poletti, Roberta ^a   Prontera, Concetta ^a   Clerico, Aldo ^a,b   Emdin, Michele ^a,b   Passino, Claudio ^a,b  

^a FONDAZIONE TOSCANA GABRIELE MONASTERIO   (Italy)

^b SCUOLA SUPERIORE SANT ANNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; HIGH SENSITIVITY TROPONIN; NORADRENALIN; TROPONIN; UNCLASSIFIED DRUG; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76); TROPONIN T;

ADULT; ARTICLE; CLINICAL ARTICLE; EXERCISE; EXERCISE TEST; FEMALE; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEART OUTPUT; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEMODYNAMICS; HUMAN; MALE; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REBREATHING; REST; SYSTOLIC HEART FAILURE; AGED; BLOOD; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDICTIVE VALUE; PROGNOSIS; TIME;

AGED; CARDIAC OUTPUT; EXERCISE; EXERCISE TEST; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; NOREPINEPHRINE; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REST; TIME FACTORS; TROPONIN T; VENTRICULAR FUNCTION, LEFT;

EID: 84938204844     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2015.05.017     Document Type: Article

References (28)

1. W. Friedl, J. Mair, S. Thomas, M. Pichler, and B. Puschendorf Relationship between natriuretic peptides and hemodynamics in patients with heart failure at rest and after ergometric exercise Clin Chim Acta 281 1999 121 126
2. A. Clerico, F.A. Recchia, C. Passino, and M. Emdin Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications Am J Physiol Heart Circ Physiol 290 2006 H17 H29
3. M. Packer The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure J Am Coll Cardiol 20 1992 248 254
4. R. Latini, S. Masson, I.S. Anand, E. Missov, M. Carlson, T. Vago, L. Angelici, S. Barlera, G. Parrinello, A.P. Maggioni, G. Tognoni, J.N. Cohn Val-HeFT Investigators Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure Circulation 116 2007 1242 1249
5. G.L. Todd, G. Baroldi, G.M. Pieper, F.C. Clayton, and R.S. Eliot Experimental catecholamine induced myocardial necrosis. Morphology, quantification and regional distribution of acute contraction band lesions J Mol Cell Cardiol 17 1985 317 338
6. J. Feng, B.J. Schaus, J.A. Fallavollita, T.C. Lee, and J.M. Canty Jr. Preload induces troponin I degradation independently of myocardial ischemia Circulation 103 2001 2035 2037
7. O. Schulz, and A. Kromer Cardiac troponin I: a potential marker of exercise intolerance in patients with moderate heart failure Am Heart J 144 2002 351 358
8. J.J. McMurray, S. Adamopoulos, S.D. Anker, A. Auricchio, M. Böhm, K. Dickstein, V. Falk, G. Filippatos, C. Fonseca, M.A. Gomez-Sanchez, T. Jaarsma, L. Køber, G.Y. Lip, A.P. Maggioni, A. Parkhomenko, B.M. Pieske, B.A. Popescu, P.K. Rønnevik, F.H. Rutten, J. Schwitter, P. Seferovic, J. Stepinska, P.T. Trindade, A.A. Voors, F. Zannad, A. Zeiher Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology J.J. Bax, H. Baumgartner, C. Ceconi, V. Dean, C. Deaton, R. Fagard, C. Funck-Brentano, D. Hasdai, A. Hoes, P. Kirchhof, J. Knuuti, P. Kolh, T. McDonagh, C. Moulin, B.A. Popescu, Z. Reiner, U. Sechtem, P.A. Sirnes, M. Tendera, A. Torbicki, A. Vahanian, S. Windecker, T. McDonagh, U. Sechtem, L.A. Bonet, P. Avraamides, H.A. Ben Lamin, M. Brignole, A. Coca, P. Cowburn, H. Dargie, P. Elliott, F.A. Flachskampf, G.F. Guida, S. Hardman, B. Iung, B. Merkely, C. Mueller, J.N. Nanas, O.W. Nielsen, S. Orn, J.T. Parissis, P. Ponikowski ESC Committee for Practice Guidelines ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur J Heart Fail 14 2012 803 869
9. M. Emdin, C. Passino, C. Prontera, A. Iervasi, A. Ripoli, S. Masini, G.C. Zucchelli, and A. Clerico Cardiac natriuretic hormones, neuro-hormones, thyroid hormones and cytokines in normal subjects and patients with heart failure Clin Chem Lab Med 42 2004 627 636
10. K. Thygesen, J.S. Alpert, A.S. Jaffe, M.L. Simoons, B.R. Chaitman, H.D. White The Writing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction Third universal definition of myocardial infarction Eur Heart J 33 2012 2551 2567
11. A. Clerico, M. Zaninotto, C. Prontera, S. Giovannini, R. Ndreu, M. Franzini, G.C. Zucchelli, M. Plebani Study Group on Cardiovascular Risk Biomarkers of the Italian Society of Clinical Biochemistry State of the art of BNP and NT-proBNP immunoassays: the cardioOrmoCheck study Clin Chim Acta 414 2012 112 119
12. C. Prontera, C.G. Zucchelli, S. Vittorini, S. Storti, M. Emdin, and A. Clerico Comparison between analytical performances of polyclonal and monoclonal electrochemiluminescence immunoassays for NT-proBNP Clin Chim Acta 400 2009 70 73
13. M. Franzini, S. Masotti, C. Prontera, C. Passino, and A. Clerico Clinical implications of a recent adjustment to the high-sensitivity cardiac troponin T assay: some results Clin Chem Lab Med 1 2013 1 3
14. R. Poletti, G. Vergaro, L. Zyw, C. Prontera, C. Passino, and M. Emdin Prognostic value of plasma rennin activity in heart failure patients with chronic kidney disease Int J Cardiol 167 2012 711 715
15. P. Agostoni, G. Cattadori, A. Apostolo, M. Contini, P. Palermo, G. Marenzi, and K. Wasserman Noninvasive measurement of cardiac output during exercise by inert gas rebreathing technique: a new tool for heart failure evaluation J Am Coll Cardiol 46 2005 1779 1781
16. J.P. Bertinchant, N. Combes, A. Polge, P. Fabbro-Peray, F. Raczka, L. Beck, S. Cade, and B. Ledermann Prognostic value of cardiac troponin T in patients with both acute and chronic stable congestive heart failure: comparison with atrial natriuretic peptide, brain natriuretic peptide and plasma norepinephrine Clin Chim Acta 352 2005 143 153
17. Y. Sato, T. Yamada, R. Taniguchi, K. Nagai, T. Makiyama, H. Okada, K. Kataoka, H. Ito, A. Matsumori, S. Sasayama, and Y. Takatsu Persistently increased serum concentrations of cardiac troponin T in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes Circulation 103 2001 369 374
18. W.L. Miller, K.A. Hartman, M.F. Burritt, D.E. Grill, R.J. Rodeheffer, J.C. Burnett Jr., and A.S. Jaffe Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time Circulation 116 2007 249 257
19. C.G. Jungbauer, J. Riedlinger, S. Buchner, C. Birner, M. Resch, M. Lubnow, K. Debl, M. Buesing, H. Huedig, G. Riegger, and A. Luchner High-sensitive troponin T in chronic heart failure correlates with severity of symptoms, left ventricular dysfunction and prognosis independently from N-terminal pro-b-type natriuretic peptide Clin Chem Lab Med 49 2011 1899 1906
20. V. Nagarajan, A.V. Hernandez, and W.H. Tang Prognostic value of cardiac troponin in chronic stable heart failure: a systematic review Heart 98 2012 1778 1786
21. M. Koç, A. Bozkurt, E. Acartürk, D.Y. Sahin, and I. Unal Usefulness of N-terminal pro-B-type natriuretic peptide increase with exercise for predicting cardiovascular mortality in patients with heart failure Am J Cardiol 101 2008 1157 1162
22. T. Kinugawa, K. Ogino, H. Kitamura, H. Miyakoda, M. Saitoh, J. Hasegawa, H. Kotake, and H. Mashiba Response of sympathetic nervous system activity to exercise in patients with congestive heart failure Eur J Clin Invest 21 1991 542 547
23. D.L. Mann, R.L. Kent, B. Parsons, and G. Cooper Adrenergic effects on the biology of the adult mammalian cardiocyte Circulation 85 1992 790 804
24. C.C. Lang, P. Agostoni, and D.M. Mancini Prognostic significance and measurement of exercise-derived hemodynamic variables in patients with heart failure J Card Fail 13 2007 672 679
25. W. Cheng, B. Li, J. Kajstura, P. Li, M.S. Wolin, E.H. Sonnenblick, T.H. Hintze, G. Olivetti, and P. Anversa Stretch-induced programmed myocyte cell death J Clin Invest 96 1995 2247 2259
26. S. Haq, G. Choukroun, H. Lim, K.M. Tymitz, F. del Monte, J. Gwathmey, L. Grazette, A. Michael, R. Hajjar, T. Force, and J.D. Molkentin Differential activation of signal transduction pathways in human hearts with hypertrophy versus advanced heart failure Circulation 103 2001 670 677
27. O. Parodi, R. De Maria, L. Oltrona, R. Testa, G. Sambuceti, A. Roghi, M. Merli, L. Belingheri, R. Accinni, and F. Spinelli Myocardial blood flow distribution in patients with ischemic heart disease or dilated cardiomyopathy undergoing heart transplantation Circulation 88 1993 509 522
28. R.P. Shannon, K. Komamura, Y.T. Shen, S.P. Bishop, and S.F. Vatner Impaired regional subendocardial coronary flow reserve in conscious dogs with pacing-induced heart failure Am J Physiol Heart Circ Physiol 265 1993 801 809